Riverhead Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-25,600
Closed -$603K 1542
2018
Q3
$603K Hold
25,600
0.02% 668
2018
Q2
$590K Hold
25,600
0.02% 623
2018
Q1
$630K Hold
25,600
0.03% 558
2017
Q4
$687K Hold
25,600
0.03% 540
2017
Q3
$616K Hold
25,600
0.03% 539
2017
Q2
$549K Hold
25,600
0.03% 549
2017
Q1
$439K Hold
25,600
0.02% 570
2016
Q4
$459K Hold
25,600
0.03% 524
2016
Q3
$532K Buy
25,600
+19,198
+300% +$476K 0.03% 448
2016
Q2
$202K Sell
6,402
-116,862
-95% -$3.2M 0.01% 898
2016
Q1
$3.34M Sell
123,264
-5,136
-4% -$138K 0.05% 409
2015
Q4
$3.73M Hold
128,400
0.05% 389
2015
Q3
$3.48M Hold
128,400
0.05% 367
2015
Q2
$3.52M Hold
128,400
0.05% 384
2015
Q1
$3.43M Hold
128,400
0.05% 382
2014
Q4
$2.72M Hold
128,400
0.04% 429
2014
Q3
$3.06M Hold
128,400
0.05% 376
2014
Q2
$2.97M Hold
128,400
0.06% 362
2014
Q1
$2.93M Buy
+128,400
New +$2.74M 0.06% 331
2013
Q3
Sell
-130,000
Closed -$2.02M 436
2013
Q2
$2.02M Buy
+130,000
New +$2.16M 0.07% 276

Other funds holding NVO

Riverhead Capital Management's NVO Position: Q4 2018 in Review

Riverhead Capital Management sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 25,600 shares — an estimated $603K sold.

Riverhead Capital Management first reported a position in NVO in Q2 2013 and held it in 20 quarters. The position peaked at $3.73M in Q4 2015. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Riverhead Capital Management reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • Riverhead Capital Management sold 25,600 Novo Nordisk shares in Q4 2018, an estimated $603K.
  • Riverhead Capital Management first reported a position in Novo Nordisk in Q2 2013 and held it in 20 quarters.
  • Riverhead Capital Management's Novo Nordisk position peaked at $3.73M in Q4 2015.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Riverhead Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.